register

News & Trends - MedTech & Diagnostics

Southern Hemisphere’s largest pathology lab opens this week

Health Industry Hub | March 13, 2023 |

MedTech News: Victoria will be the epicentre of world-leading scientific research and development with the opening of the Southern Hemisphere’s largest testing laboratory in Ravenhall on Thursday, 16 March.

Leading analytical testing provider Symbio Laboratories is proud to open the state-of-the-art Ravenhall facility, where it will drive innovation in scientific testing, including in the development of tests for virus detection and early cancer diagnosis.

Symbio Laboratories Managing Director, Bruce Chen, said the new laboratory is a significant investment in the future of science and technology.

“We are committed to staying at the forefront of technology and innovation, and this new, world-class facility will allow us to do just that,” Mr Chen said.

“The facility is equipped with the latest technology and equipment to support innovative research and development and holds the title of the Southern Hemisphere’s largest laboratory of its kind.

“Not only will it push the boundaries of scientific research and development, but it will also bring 200 new job opportunities to the local community.”

Australian-owned Symbio Laboratories is a market leader in the provision of rapid turnaround, high-quality analytical testing of food, agriculture, pharmaceutical products, cosmetics, water, and other environmental samples. It services almost 8,000 clients throughout Australia, conducting 35,000 tests on more than 11,000 samples each week.

Along with this core work, almost 40 per cent of the 8,600sqm, three-level Ravenhall lab will be dedicated to research and development. Its R&D commitment includes plans to genetically map human illnesses for the development of rapid tests to detect viruses before they can evolve and become resistant to specific drug treatments, as well as tests providing early diagnosis of cancers, such as breast and ovarian cancers and chronic myeloid leukaemia.

The new lab will also spearhead developments in genome sequencing and PCR based tests to provide Australia with cutting-edge, local solutions to complex public health challenges gripping the globe.

Microbiology expert Professor Enzo Palombo, from Swinburne University, will be a guest speaker at the Ravenhall laboratory’s official opening. Professor Palombo will speak about the important role the new lab will play in the future of diagnostics.

Bronwyn Halfpenny MP, Parliamentary Secretary for Jobs and Member for Thomastown, and Councillor Lara Carli, Mayor of Melton will join Mr Chen at the opening ceremony.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Aussie medtech forges ahead, making inroads with new technology

Aussie medtech forges ahead, making inroads with new technology

Health Industry Hub | February 23, 2024 |

MedTech & Diagnostics News: Adelaide-based medical technology firm, LBT Innovations has successfully delivered its cutting-edge Automated Plate Assessment System (APAS) […]

More


News & Trends - Pharmaceuticals

Is the imposed PBS funding cap driving the migraine medicines shortage?

Is the imposed PBS funding cap driving the migraine medicines shortage?

Health Industry Hub | February 23, 2024 |

Pharma News: Australia finds itself grappling with an unparalleled shortage of migraine prevention medicines, leaving a significant impact on the […]

More


News & Trends - Pharmaceuticals

MSAC rejects Janssen's CAR T therapy despite clinical superiority, citing need for 'substantial price reduction'

MSAC rejects Janssen’s CAR T therapy despite clinical superiority, citing need for ‘substantial price reduction’

Health Industry Hub | February 23, 2024 |

Pharma News: The Medical Services Advisory Committee (MSAC) has deferred its decision on whether Janssen’s CAR T-cell therapy Carvykti (cilta-cel) […]

More


News & Trends - Pharmaceuticals

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Gedeon Richter secures first endometriosis treatment in over a decade, with experts pushing for extension of NAPE

Health Industry Hub | February 23, 2024 |

Pharma News: The Therapeutic Goods Administration (TGA) has granted approval for the first endometriosis treatment in 13 years. Gedeon Richter […]

More


This content is copyright protected. Please subscribe to gain access.